127 related articles for article (PubMed ID: 37549604)
1. Secreted frizzled-related protein 5: A promising therapeutic target for metabolic diseases via regulation of Wnt signaling.
Song Y; Ma Y; Zhang K; Zhang W; Xiong G; Qi T; Shi J; Qiu H; Zhang J; Han F; Kan C; Sun X
Biochem Biophys Res Commun; 2023 Oct; 677():70-76. PubMed ID: 37549604
[TBL] [Abstract][Full Text] [Related]
2. The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus.
Liu LB; Chen XD; Zhou XY; Zhu Q
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29789397
[TBL] [Abstract][Full Text] [Related]
3. Secreted frizzled-related protein 5 suppresses adipocyte mitochondrial metabolism through WNT inhibition.
Mori H; Prestwich TC; Reid MA; Longo KA; Gerin I; Cawthorn WP; Susulic VS; Krishnan V; Greenfield A; Macdougald OA
J Clin Invest; 2012 Jul; 122(7):2405-16. PubMed ID: 22728933
[TBL] [Abstract][Full Text] [Related]
4. Frizzled receptors and SFRP5 in lipid metabolism: Current findings and potential applications.
Chu DT; Nguyen TL
Prog Mol Biol Transl Sci; 2023; 194():377-393. PubMed ID: 36631199
[TBL] [Abstract][Full Text] [Related]
5. Secreted Frizzled-Related Protein 5 Attenuates High Phosphate-Induced Calcification in Vascular Smooth Muscle Cells by Inhibiting the Wnt/ß-Catenin Pathway.
Deng D; Diao Z; Han X; Liu W
Calcif Tissue Int; 2016 Jul; 99(1):66-75. PubMed ID: 26895007
[TBL] [Abstract][Full Text] [Related]
6. Research Progress on the Mechanism of the SFRP-Mediated Wnt Signalling Pathway Involved in Bone Metabolism in Osteoporosis.
An F; Song J; Chang W; Zhang J; Gao P; Wang Y; Xiao Z; Yan C
Mol Biotechnol; 2024 May; 66(5):975-990. PubMed ID: 38194214
[TBL] [Abstract][Full Text] [Related]
7. Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.
Tong S; Ji Q; Du Y; Zhu X; Zhu C; Zhou Y
J Interferon Cytokine Res; 2019 Aug; 39(8):472-482. PubMed ID: 31199714
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic silencing of SFRP5 promotes the metastasis and invasion of chondrosarcoma by expression inhibition and Wnt signaling pathway activation.
Sheng W; Zhang ZC; Shi DY; Wang BC; Wu Q; Shao ZW; Yang SH; He TC; Liu JX
Chem Biol Interact; 2018 Dec; 296():1-8. PubMed ID: 30125549
[TBL] [Abstract][Full Text] [Related]
9. Sfrp5 correlates with insulin resistance and oxidative stress.
Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J
Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sfrp5 on cytokine release and insulin action in primary human adipocytes and skeletal muscle cells.
Carstensen M; Wiza C; Röhrig K; Fahlbusch P; Roden M; Herder C; Ouwens DM
PLoS One; 2014; 9(1):e85906. PubMed ID: 24465779
[TBL] [Abstract][Full Text] [Related]
11. Activation of noncanonical Wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Pérez-Hernández AI; Gurbindo J; Ramírez B; Méndez-Giménez L; Rotellar F; Valentí V; Moncada R; Martí P; Sola I; Silva C; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2014 Aug; 99(8):E1407-17. PubMed ID: 24840810
[TBL] [Abstract][Full Text] [Related]
12. Emergence of SFRP5 as a pleiotropic adipocytokine and its association with Wnt signaling pathways.
Jaikanth C; Gurumurthy P; Indhumathi T; Cherian KM
Minerva Endocrinol; 2017 Sep; 42(3):280-289. PubMed ID: 25003224
[TBL] [Abstract][Full Text] [Related]
13. Sfrp5 is an anti-inflammatory adipokine that modulates metabolic dysfunction in obesity.
Ouchi N; Higuchi A; Ohashi K; Oshima Y; Gokce N; Shibata R; Akasaki Y; Shimono A; Walsh K
Science; 2010 Jul; 329(5990):454-7. PubMed ID: 20558665
[TBL] [Abstract][Full Text] [Related]
14. Secreted Frizzled-Related Protein 5 Ameliorates Vascular Calcification in a Rat Model of Chronic Kidney Disease through the Wnt/β-Catenin Pathway.
Deng D; Han X; Diao Z; Liu W
Kidney Blood Press Res; 2021; 46(6):758-767. PubMed ID: 34469882
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the Wnt inhibitors secreted frizzled-related proteins (SFRPs) in human adipose tissue.
Ehrlund A; Mejhert N; Lorente-Cebrián S; Aström G; Dahlman I; Laurencikiene J; Rydén M
J Clin Endocrinol Metab; 2013 Mar; 98(3):E503-8. PubMed ID: 23393180
[TBL] [Abstract][Full Text] [Related]
16. Balanced duo of anti-inflammatory SFRP5 and proinflammatory WNT5A in children.
Prats-Puig A; Soriano-Rodríguez P; Carreras-Badosa G; Riera-Pérez E; Ros-Miquel M; Gomila-Borja A; de Zegher F; Ibáñez L; Bassols J; López-Bermejo A
Pediatr Res; 2014 Jun; 75(6):793-7. PubMed ID: 24603290
[TBL] [Abstract][Full Text] [Related]
17. SFRP5 acts as a mature adipocyte marker but not as a regulator in adipogenesis.
Wang R; Hong J; Liu R; Chen M; Xu M; Gu W; Zhang Y; Ma Q; Wang F; Shi J; Wang J; Wang W; Ning G
J Mol Endocrinol; 2014 Dec; 53(3):405-15. PubMed ID: 25324487
[TBL] [Abstract][Full Text] [Related]
18. Hyperactivated Wnt-β-catenin signaling in the absence of sFRP1 and sFRP5 disrupts trophoblast differentiation through repression of Ascl2.
Bao H; Liu D; Xu Y; Sun Y; Mu C; Yu Y; Wang C; Han Q; Liu S; Cai H; Liu F; Kong S; Deng W; Cao B; Wang H; Wang Q; Lu J
BMC Biol; 2020 Oct; 18(1):151. PubMed ID: 33109217
[TBL] [Abstract][Full Text] [Related]
19. Circulating secreted frizzled-related protein 5 (Sfrp5) and wingless-type MMTV integration site family member 5a (Wnt5a) levels in patients with type 2 diabetes mellitus.
Lu YC; Wang CP; Hsu CC; Chiu CA; Yu TH; Hung WC; Lu LF; Chung FM; Tsai IT; Lin HC; Lee YJ
Diabetes Metab Res Rev; 2013 Oct; 29(7):551-6. PubMed ID: 23653377
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is associated with Sfrp5 in obstructive sleep apnea.
Sun S; Zhai H; Zhu M; Wen P; He X; Wang H
Braz J Otorhinolaryngol; 2019; 85(6):739-745. PubMed ID: 30120048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
